NRXP Stock Analysis: Buy, Sell, or Hold?
NRXP - NRX Pharmaceuticals, Inc. Common Stock
$3.56
0.05 (1.42%)
▲
5d:
+8.87%
30d:
-13.38%
90d:
+16.34%
BUY
HIGH Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 17, 2026
0d
Get Alerted When NRXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NRXP trading at deep discount. Market pricing in -10.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: NRXP trading at deep discount. Market pricing in -10.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.94
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.31
17.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRXP is currently trading at $3.56, which is considered slightly low relative to its 30-day fair value range of $3.20 to $4.19. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.1) compared to its historical average (9.9). Remarkably, the market is currently pricing in an annual earnings decline of 10.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NRXP is in a uptrend. Immediate support is located at $3.09, while resistance sits at $3.67.
Market Sentiment: NRXP scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $38.25 (+974.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NRXP is in a uptrend. Immediate support is located at $3.09, while resistance sits at $3.67.
Market Sentiment: NRXP scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $38.25 (+974.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.20 -
$4.19
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 974.4% below Wall St target ($38.25)
- BULLISH: Bottoming setup score 70/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$3.20 -
$4.19
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.09
Resistance Level
$3.67
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.12
Wall Street Target
$38.25
(+974.4%)
Valuation Discount vs History
-10.3% cheaper
PE vs Historical
7.1 vs 9.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.3%
(market-implied from PE analysis)
1-Year Target
$3.20
(-10%)
2-Year Target
$2.88
(-19%)
3-Year Target
$2.60
(-27%)
3-Yr Target (if PE normalizes)
(PE: 7→10)
$3.61
(+1%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.1 to 9.9
Stabilization Target:
$4.95
(+39.0%)
PE Expansion Potential:
+39.0%
Share & Embed Analysis
Last updated: August 23, 2026 2:19 PM ET
Data refreshes hourly during market hours. Next update: 3:19 PM
Data refreshes hourly during market hours. Next update: 3:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 40 SELL |
Advanced NRXP Option Strategies
Professional options setups generated by AI based on today's NRXP price and gamma walls.
